HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor.

Abstract
Despite recent advances in therapeutic strategies against hepatitis B virus (HBV) infection, chronic hepatitis B remains a major global health burden. Recent studies have shown that targeting host factors instead of viral factors can be an effective antiviral strategy with low risk of the development of resistance. Efforts to identify host factors affecting viral replication have identified p38 mitogen-activated protein kinase (MAPK) as a possible target for antiviral strategies against various viruses, including HBV. Here, a series of biphenyl amides were synthesized as novel p38 MAPK selective inhibitors and assessed for their anti-HBV activities. The suppression of HBV surface antigen (HBsAg) production by these compounds was positively correlated with p38 MAPK-inhibitory activity. The selected compound NJK14047 displayed significant anti-HBV activity, as determined by HBsAg production, HBeAg secretion, and HBV production. NJK14047 efficiently suppressed the secretion of HBV antigens and HBV particles from HBV genome-transfected cells and HBV-infected sodium taurocholate cotransporting polypeptide-expressing human hepatoma cells. Furthermore, NJK14047 treatment resulted in a significant decrease of pregenomic RNA and covalently closed circular DNA (cccDNA) of HBV in HBV-harboring cells, indicating its ability to inhibit HBV replication. Considering that suppression of HBsAg secretion and elimination of cccDNA of HBV are the major aims of anti-HBV therapeutic strategies, the results suggested the potential use of these compounds as a novel class of anti-HBV agents targeting host factors critical for viral infection.
AuthorsSo-Young Kim, Hong Kim, Sang-Won Kim, Na-Rae Lee, Chae-Min Yi, Jinyuk Heo, Bum-Joon Kim, Nam-Jung Kim, Kyung-Soo Inn
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 61 Issue 8 (08 2017) ISSN: 1098-6596 [Electronic] United States
PMID28559272 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2017 American Society for Microbiology.
Chemical References
  • Amides
  • Antiviral Agents
  • Biphenyl Compounds
  • DNA, Circular
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Protein Kinase Inhibitors
  • diphenyl
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Amides (chemistry, pharmacology)
  • Antiviral Agents (chemistry, pharmacology)
  • Biphenyl Compounds (chemistry, pharmacology)
  • Cell Survival
  • DNA, Circular (analysis)
  • Hepatitis B Surface Antigens (drug effects)
  • Hepatitis B e Antigens (drug effects)
  • Hepatitis B virus (drug effects, physiology)
  • Hepatitis B, Chronic (drug therapy, virology)
  • Humans
  • Protein Kinase Inhibitors (chemistry, pharmacology)
  • Virus Replication (drug effects)
  • p38 Mitogen-Activated Protein Kinases (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: